Biomerica (BMRA) Share-based Compensation (2011 - 2026)
Biomerica (BMRA) reported Share-based Compensation of $58000.0 for Q1 2026, down 51.67% on a YoY basis from $120000.0 in Q1 2025, and down 19.44% sequentially from $72000.0 in Q4 2025.
Biomerica (BMRA) Share-based Compensation (2011 - 2026) Analysis & Trends
Biomerica (BMRA) has 16 years of Share-based Compensation data on file, last reported at $58000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 51.67% year-over-year to $58000.0; the trailing twelve-month figure through Feb 2026 stood at $400000.0 (down 28.06% YoY), and the FY2025 full-year result was $535000.0, down 57.71% from the prior year.
- Share-based Compensation eased to $58000.0 in Q1 2026, from $72000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $384000.0 in Q1 2023 to a low of $58000.0 in Q1 2026.
- A 5-year average of $199941.2 and a median of $170000.0 in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation jumped 1212.59% in 2022 and plunged 64.71% in 2025, its largest moves.
- Tracing BMRA's Share-based Compensation over 5 years: stood at $318000.0 in 2022, then sank by 61.64% to $122000.0 in 2023, then climbed by 27.05% to $155000.0 in 2024, then slumped by 53.55% to $72000.0 in 2025, then dropped by 19.44% to $58000.0 in 2026.
- Business Quant data shows BMRA's Share-based Compensation at $58000.0 in Q1 2026, $72000.0 in Q4 2025, and $133000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 58,000.00 |
| Feb 28, 2026 | 58,000.00 |
| Nov 30, 2025 | 72,000.00 |
| Nov 30, 2025 | 72,000.00 |
| Aug 31, 2025 | 133,000.00 |
| Aug 31, 2025 | 133,000.00 |
| May 31, 2025 | 137,000.00 |
| May 31, 2025 | 137,000.00 |
| Feb 28, 2025 | 120,000.00 |
| Feb 28, 2025 | 120,000.00 |
| Nov 30, 2024 | 155,000.00 |
| Nov 30, 2024 | 155,000.00 |
| Aug 31, 2024 | 77,000.00 |
| Aug 31, 2024 | 77,000.00 |
| May 31, 2024 | 204,000.00 |
| May 31, 2024 | 204,000.00 |
| Feb 29, 2024 | 340,000.00 |
| Feb 29, 2024 | 340,000.00 |
| Nov 30, 2023 | 122,000.00 |
| Nov 30, 2023 | 122,000.00 |